299 related articles for article (PubMed ID: 37050853)
1. Retraction.
Cancer Med; 2023 May; 12(9):11041. PubMed ID: 37050853
[TBL] [Abstract][Full Text] [Related]
2. Retracted: 14-3-3ζ promotes gliomas cells invasion by regulating Snail through the PI3K/AKT signaling.
Cancer Med; 2023 Jul; 12(14):15761. PubMed ID: 37439554
[TBL] [Abstract][Full Text] [Related]
3. Retraction.
Cancer Med; 2023 Sep; 12(18):19352. PubMed ID: 37724781
[TBL] [Abstract][Full Text] [Related]
4. Retraction.
Cancer Med; 2023 May; 12(9):11040. PubMed ID: 37046403
[TBL] [Abstract][Full Text] [Related]
5. Retraction.
Cancer Med; 2023 May; 12(10):12034. PubMed ID: 37097252
[TBL] [Abstract][Full Text] [Related]
6. Retraction.
Cancer Med; 2023 Dec; 12(24):22437. PubMed ID: 38100296
[TBL] [Abstract][Full Text] [Related]
7. Retraction.
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38108614
[TBL] [Abstract][Full Text] [Related]
8. Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.
FEBS Open Bio; 2023 Aug; 13(8):1540. PubMed ID: 37410095
[TBL] [Abstract][Full Text] [Related]
9. Retraction: lncRNA HOTAIR promotes gastric cancer proliferation and metastasis via targeting miR-126 to active CXCR4 and RhoA signaling pathway.
Cancer Med; 2024 May; 13(9):e7220. PubMed ID: 38695659
[TBL] [Abstract][Full Text] [Related]
10. Retraction: Wang Y, Yue D. CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/β-catenin signaling pathway.
Cancer Med; 2024 Apr; 13(7):e7138. PubMed ID: 38546000
[TBL] [Abstract][Full Text] [Related]
11. Retraction.
Cancer Sci; 2023 Jul; 114(7):3057. PubMed ID: 37211924
[TBL] [Abstract][Full Text] [Related]
12. Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
Asia Pac J Clin Oncol; 2023 Dec; 19(6):762. PubMed ID: 37888963
[TBL] [Abstract][Full Text] [Related]
13. Retraction: lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2.
Cancer Med; 2024 Mar; 13(5):e7098. PubMed ID: 38470371
[TBL] [Abstract][Full Text] [Related]
14. Retraction.
Int J Gynaecol Obstet; 2023 Aug; 162(2):784. PubMed ID: 37210671
[TBL] [Abstract][Full Text] [Related]
15. Retraction statement: Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.
Mol Oncol; 2023 Aug; 17(8):1692. PubMed ID: 37471281
[TBL] [Abstract][Full Text] [Related]
16. Retraction.
Int J Gynaecol Obstet; 2023 Sep; 162(3):1127. PubMed ID: 37358060
[TBL] [Abstract][Full Text] [Related]
17. Retracted: Chen, Y, Zhang, W, Kadier, A, Zhang, H, Yao, X. MicroRNA-769-5p suppresses cell growth and migration via targeting NUSAP1 in bladder cancer. J Clin Lab Anal. 2020; 34:e23193.
J Clin Lab Anal; 2023 Apr; 37(8):e24893. PubMed ID: 37183304
[TBL] [Abstract][Full Text] [Related]
18. Withdrawal Notice.
Cancer Med; 2023 Sep; 12(18):19353. PubMed ID: 36372952
[TBL] [Abstract][Full Text] [Related]
19. Retraction.
Int J Gynaecol Obstet; 2023 Sep; 162(3):1128. PubMed ID: 37303080
[TBL] [Abstract][Full Text] [Related]
20. Retraction.
J Cell Physiol; 2022 Mar; 237(3):2013. PubMed ID: 34287868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
